{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:59:54Z","timestamp":1792609194136,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA218875"],"award-info":[{"award-number":["CA218875"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA228815"],"award-info":[{"award-number":["CA228815"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biomed Eng"],"DOI":"10.1038\/s41551-020-0526-9","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T12:03:58Z","timestamp":1584014638000},"page":"272-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1908-1782","authenticated-orcid":false,"given":"Susanne","family":"Kossatz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8862-3613","authenticated-orcid":false,"given":"Giacomo","family":"Pirovano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Dem\u00e9trio De Souza Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna L.","family":"Strome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumsum P.","family":"Sunny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella Karassawa","family":"Zanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mauguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-9455","authenticated-orcid":false,"given":"Veer","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra D.","family":"Ramanajinappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Hedne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5287-8323","authenticated-orcid":false,"given":"Praveen","family":"Birur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Sihag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Ghossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Strome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amritha","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Molena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ganly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moni A.","family":"Kuriakose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal G.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7819-5480","authenticated-orcid":false,"given":"Thomas","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"526_CR1","unstructured":"Cancer stat facts: oral cavity and pharynx cancer. National Cancer Institute Surveillance, Epidemiology, and End Results Program https:\/\/seer.cancer.gov\/statfacts\/html\/oralcav.html (2018)."},{"key":"526_CR2","unstructured":"Cancer stat facts: esophageal cancer. National Cancer Institute Surveillance, Epidemiology, and End Results Program https:\/\/seer.cancer.gov\/statfacts\/html\/esoph.html (2018)."},{"key":"526_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1054\/ijom.2002.0313","volume":"32","author":"DN Sutton","year":"2003","unstructured":"Sutton, D. N., Brown, J. S., Rogers, S. N., Vaughan, E. D. & Woolgar, J. A. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J. Oral Maxillofac. Surg. 32, 30\u201334 (2003).","journal-title":"Int J. Oral Maxillofac. Surg."},{"key":"526_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/cncr.26229","volume":"118","author":"I Ganly","year":"2012","unstructured":"Ganly, I., Patel, S. & Shah, J. Early stage squamous cell cancer of the oral tongue\u2014clinicopathologic features affecting outcome. Cancer 118, 101\u2013111 (2012).","journal-title":"Cancer"},{"key":"526_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0002-9610(98)00140-8","volume":"176","author":"S Law","year":"1998","unstructured":"Law, S., Arcilla, C., Chu, K. M. & Wong, J. The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am. J. Surg. 176, 286\u2013290 (1998).","journal-title":"Am. J. Surg."},{"key":"526_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1758-3284-1-5","volume":"1","author":"S Fedele","year":"2009","unstructured":"Fedele, S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 1, 5 (2009).","journal-title":"Head Neck Oncol."},{"key":"526_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.oraloncology.2007.06.011","volume":"44","author":"MW Lingen","year":"2008","unstructured":"Lingen, M. W., Kalmar, J. R., Karrison, T. & Speight, P. M. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 44, 10\u201322 (2008).","journal-title":"Oral Oncol."},{"key":"526_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/hed.23667","volume":"37","author":"C Fuller","year":"2015","unstructured":"Fuller, C. et al. Adjunctive diagnostic techniques for oral lesions of unknown malignant potential: systematic review with meta-analysis. Head Neck 37, 755\u2013762 (2015).","journal-title":"Head Neck"},{"key":"526_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/pharmaceutics3030354","volume":"3","author":"M Olivo","year":"2011","unstructured":"Olivo, M., Bhuvaneswari, R. & Keogh, I. Advances in bio-optical imaging for the diagnosis of early oral cancer. Pharmaceutics 3, 354\u2013378 (2011).","journal-title":"Pharmaceutics"},{"key":"526_CR10","doi-asserted-by":"publisher","first-page":"153601211880864","DOI":"10.1177\/1536012118808644","volume":"17","author":"A Strome","year":"2018","unstructured":"Strome, A. et al. Current practice and emerging molecular imaging technologies in oral cancer screening. Mol. Imaging 17, 1536012118808644 (2018).","journal-title":"Mol. Imaging"},{"key":"526_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.oooo.2018.02.020","volume":"125","author":"EC Yang","year":"2018","unstructured":"Yang, E. C. et al. Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions. Oral Surg. Oral Med. Oral Pathol. Oral. Radio. 125, 670\u2013681 (2018).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral. Radio."},{"key":"526_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2217\/fon.10.79","volume":"6","author":"D Shin","year":"2010","unstructured":"Shin, D., Vigneswaran, N., Gillenwater, A. & Richards-Kortum, R. Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol. 6, 1143\u20131154 (2010).","journal-title":"Future Oncol."},{"key":"526_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.14219\/jada.archive.2008.0276","volume":"139","author":"LL Patton","year":"2008","unstructured":"Patton, L. L., Epstein, J. B. & Kerr, A. R. Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J. Am. Dent. Assoc. 139, 896\u2013905 (2008). quiz 993-894.","journal-title":"J. Am. Dent. Assoc."},{"key":"526_CR14","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.ejca.2006.01.061","volume":"42","author":"K Nosho","year":"2006","unstructured":"Nosho, K. et al. Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. Eur. J. Cancer 42, 2374\u20132381 (2006).","journal-title":"Eur. J. Cancer"},{"key":"526_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.humpath.2005.04.017","volume":"36","author":"S Staibano","year":"2005","unstructured":"Staibano, S. et al. Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region. Hum. Pathol. 36, 724\u2013731 (2005).","journal-title":"Hum. Pathol."},{"key":"526_CR16","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1158\/1535-7163.MCT-13-0010","volume":"12","author":"JP Chow","year":"2013","unstructured":"Chow, J. P. et al. PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy. Mol. Cancer Therapeutics 12, 2517\u20132528 (2013).","journal-title":"Mol. Cancer Therapeutics"},{"key":"526_CR17","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.4081\/ejh.2013.e13","volume":"57","author":"M Salemi","year":"2013","unstructured":"Salemi, M. et al. Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue. Eur. J. Histochemistry 57, e13 (2013).","journal-title":"Eur. J. Histochemistry"},{"key":"526_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10549-014-3230-1","volume":"149","author":"AR Green","year":"2015","unstructured":"Green, A. R. et al. Biological and clinical significance of PARP1 protein expression in breast cancer. Breast Cancer Res. Treat. 149, 353\u2013362 (2015).","journal-title":"Breast Cancer Res. Treat."},{"key":"526_CR19","doi-asserted-by":"publisher","first-page":"e115558","DOI":"10.1371\/journal.pone.0115558","volume":"9","author":"T Dziaman","year":"2014","unstructured":"Dziaman, T. et al. PARP-1 expression is increased in colon adenoma and carcinoma and correlates with OGG1. PLoS ONE 9, e115558 (2014).","journal-title":"PLoS ONE"},{"key":"526_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/1947601910383418","volume":"1","author":"V Ossovskaya","year":"2010","unstructured":"Ossovskaya, V., Koo, I. C., Kaldjian, E. P., Alvares, C. & Sherman, B. M. Upregulation of poly (ADP-Ribose) polymerase-1 (PARP1) in triple-negative breast cancer and other primary human tumour types. Genes Cancer 1, 812\u2013821 (2010).","journal-title":"Genes Cancer"},{"key":"526_CR21","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1093\/annonc\/mdv393","volume":"26","author":"J Michels","year":"2015","unstructured":"Michels, J. et al. Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer. Ann. Oncol. 26, 2470\u20132477 (2015).","journal-title":"Ann. Oncol."},{"key":"526_CR22","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/annonc\/mdr361","volume":"23","author":"F Rojo","year":"2012","unstructured":"Rojo, F. et al. Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann. Oncol. 23, 1156\u20131164 (2012).","journal-title":"Ann. Oncol."},{"key":"526_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/gtmb.2018.0085","volume":"22","author":"H Pashaiefar","year":"2018","unstructured":"Pashaiefar, H. et al. PARP-1 overexpression as an independent prognostic factor in adult non-M3 acute myeloid leukemia. Genet. Test. Mol. Biomark. 22, 343\u2013349 (2018).","journal-title":"Genet. Test. Mol. Biomark."},{"key":"526_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3233\/CBM-160605","volume":"16","author":"ZH Li","year":"2016","unstructured":"Li, Z. H. et al. PARP1 is a novel independent prognostic factor for the poor prognosis of chordoma. Cancer Biomark. 16, 633\u2013639 (2016).","journal-title":"Cancer Biomark."},{"key":"526_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.neo.2014.05.005","volume":"16","author":"CP Irwin","year":"2014","unstructured":"Irwin, C. P. et al. PARPi-FL\u2014a fluorescent PARP1 inhibitor for glioblastoma imaging. Neoplasia 16, 432\u2013440 (2014).","journal-title":"Neoplasia"},{"key":"526_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep21371","volume":"6","author":"S Kossatz","year":"2016","unstructured":"Kossatz, S. et al. Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent. Sci. Rep. 6, 21371 (2016).","journal-title":"Sci. Rep."},{"key":"526_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2967\/jnumed.115.158915","volume":"57","author":"EL Rosenthal","year":"2016","unstructured":"Rosenthal, E. L. et al. Successful translation of fluorescence navigation during oncologic surgery: a consensus report. J. Nucl. Med. 57, 144\u2013150 (2016).","journal-title":"J. Nucl. Med."},{"key":"526_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.cgh.2008.11.024","volume":"7","author":"R Kariv","year":"2009","unstructured":"Kariv, R. et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin. Gastroenterol. Hepatol. 7, 653\u2013658 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"526_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S0016-5107(00)70290-2","volume":"51","author":"MI Canto","year":"2000","unstructured":"Canto, M. I. et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett\u2019s esophagus. Gastrointest. Endosc. 51, 560\u2013568 (2000).","journal-title":"Gastrointest. Endosc."},{"key":"526_CR30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.gie.2008.06.056","volume":"69","author":"S Ngamruengphong","year":"2009","unstructured":"Ngamruengphong, S., Sharma, V. K. & Das, A. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett\u2019s esophagus: a meta-analysis. Gastrointest. Endosc. 69, 1021\u20131028 (2009).","journal-title":"Gastrointest. Endosc."},{"key":"526_CR31","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/1097-0142(19901115)66:10<2068::AID-CNCR2820661005>3.0.CO;2-W","volume":"66","author":"H Shiozaki","year":"1990","unstructured":"Shiozaki, H. et al. Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer 66, 2068\u20132071 (1990).","journal-title":"Cancer"},{"key":"526_CR32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/lary.26472","volume":"127","author":"AA Patel","year":"2017","unstructured":"Patel, A. A., Strome, M. & Blitzer, A. Directed balloon cytology of the esophagus: a novel device for obtaining circumferential cytologic sampling. Laryngoscope 127, 1032\u20131035 (2017).","journal-title":"Laryngoscope"},{"key":"526_CR33","doi-asserted-by":"publisher","first-page":"eaao5848","DOI":"10.1126\/scitranslmed.aao5848","volume":"10","author":"HR Moinova","year":"2018","unstructured":"Moinova, H. R. et al. Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett\u2019s esophagus. Sci. Transl. Med. 10, eaao5848 (2018).","journal-title":"Sci. Transl. Med."},{"key":"526_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","volume":"45","author":"S Warnakulasuriya","year":"2009","unstructured":"Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45, 309\u2013316 (2009).","journal-title":"Oral Oncol."},{"key":"526_CR35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.oraloncology.2010.02.010","volume":"46","author":"S Johnson","year":"2010","unstructured":"Johnson, S., Corsten, M. J., McDonald, J. T. & Chun, J. Socio-economic factors and stage at presentation of head and neck cancer patients in Ottawa, Canada: a logistic regression analysis. Oral Oncol. 46, 366\u2013368 (2010).","journal-title":"Oral Oncol."},{"key":"526_CR36","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1002\/ijc.23430","volume":"122","author":"DI Conway","year":"2008","unstructured":"Conway, D. I. et al. Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case-control studies. Int. J. Cancer 122, 2811\u20132819 (2008).","journal-title":"Int. J. Cancer"},{"key":"526_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87\u2013108 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"526_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-3284-3-33","volume":"3","author":"R Mehrotra","year":"2011","unstructured":"Mehrotra, R. & Gupta, D. K. Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol. 3, 33 (2011).","journal-title":"Head Neck Oncol."},{"key":"526_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1067\/moe.2002.123373","volume":"93","author":"MS Greenberg","year":"2002","unstructured":"Greenberg, M. S. The \u201cbrush\u201d controversy. Oral Surg. Oral Med. Oral Pathol. Oral Radio. Endod. 93, 217\u2013218 (2002).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radio. Endod."},{"key":"526_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/dc.21581","volume":"40","author":"R Mehrotra","year":"2012","unstructured":"Mehrotra, R. The role of cytology in oral lesions: a review of recent improvements. Diagn. Cytopathol. 40, 73\u201383 (2012).","journal-title":"Diagn. Cytopathol."},{"key":"526_CR41","first-page":"Ab131","volume":"61","author":"P Fusaroli","year":"2005","unstructured":"Fusaroli, P. et al. Histology vs brush cytology (BC) in the diagnosis and follow up of Barrett\u2019s esophagus (BE). Gastrointest. Endosc. 61, Ab131\u2013Ab131 (2005).","journal-title":"Gastrointest. Endosc."},{"key":"526_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/dote\/10.4.233","volume":"10","author":"RH Hardwick","year":"1997","unstructured":"Hardwick, R. H., Morgan, R. J., Warren, B. F., Lott, M. & Alderson, D. Brush cytology in the diagnosis of neoplasia in Barrett\u2019s esophagus. Dis. Esophagus 10, 233\u2013237 (1997).","journal-title":"Dis. Esophagus"},{"key":"526_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.biopha.2018.07.114","volume":"107","author":"S D\u2019Souza","year":"2018","unstructured":"D\u2019Souza, S. & Addepalli, V. Preventive measures in oral cancer: an overview. Biomed. Pharmacother. 107, 72\u201380 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"526_CR44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0266-4356(03)00119-0","volume":"41","author":"J McMahon","year":"2003","unstructured":"McMahon, J. et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br. J. Oral Maxillofac. Surg. 41, 224\u2013231 (2003).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"526_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S1010-5182(05)80339-7","volume":"19","author":"LA Ravasz","year":"1991","unstructured":"Ravasz, L. A., Slootweg, P. J., Hordijk, G. J., Smit, F. & van der Tweel, I. The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J. Craniomaxillofac. Surg. 19, 314\u2013318 (1991).","journal-title":"J. Craniomaxillofac. Surg."},{"key":"526_CR46","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00405-012-2317-8","volume":"270","author":"M Alicandri-Ciufelli","year":"2013","unstructured":"Alicandri-Ciufelli, M. et al. Surgical margins in head and neck squamous cell carcinoma: what is \u2018close\u2019? Eur. Arch. Otorhinolaryngol. 270, 2603\u20132609 (2013).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"526_CR47","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/cncr.22347","volume":"107","author":"C Black","year":"2006","unstructured":"Black, C., Marotti, J., Zarovnaya, E. & Paydarfar, J. Critical evaluation of frozen section margins in head and neck cancer resections. Cancer 107, 2792\u20132800 (2006).","journal-title":"Cancer"},{"key":"526_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tripleo.2008.09.028","volume":"107","author":"KA Pathak","year":"2009","unstructured":"Pathak, K. A. et al. Impact of use of frozen section assessment of operative margins on survival in oral cancer. Oral Surg. Oral Med. Oral Pathol. Oral Radio. Endod. 107, 235\u2013239 (2009).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radio. Endod."},{"key":"526_CR49","doi-asserted-by":"publisher","first-page":"153601211772378","DOI":"10.1177\/1536012117723786","volume":"16","author":"S Kossatz","year":"2017","unstructured":"Kossatz, S., Weber, W. & Reiner, T. Detection and delineation of oral cancer with a PARP1-targeted optical imaging agent. Mol. Imaging 16, 1536012117723786 (2017).","journal-title":"Mol. Imaging"},{"key":"526_CR50","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2967\/jnumed.117.189936","volume":"58","author":"B Carney","year":"2017","unstructured":"Carney, B., Kossatz, S. & Reiner, T. Molecular Imaging of PARP. J. Nucl. Med. 58, 1025\u20131030 (2017).","journal-title":"J. Nucl. Med."},{"key":"526_CR51","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1158\/1535-7163.MCT-13-0801","volume":"13","author":"GM Thurber","year":"2014","unstructured":"Thurber, G. M., Reiner, T., Yang, K. S., Kohler, R. H. & Weissleder, R. Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors. Mol. Cancer Ther. 13, 986\u2013995 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"526_CR52","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nm.2472","volume":"17","author":"GM van Dam","year":"2011","unstructured":"van Dam, G. M. et al. Intraoperative tumour-specific fluorescence imaging in ovarian cancer by folate receptor-\u03b1 targeting: first in-human results. Nat. Med. 17, 1315\u20131319 (2011).","journal-title":"Nat. Med."},{"key":"526_CR53","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.7150\/thno.27384","volume":"8","author":"WS Tummers","year":"2018","unstructured":"Tummers, W. S. et al. Recommendations for reporting on emerging optical imaging agents to promote clinical approval. Theranostics 8, 5336\u20135347 (2018).","journal-title":"Theranostics"},{"key":"526_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02096-w","volume":"9","author":"B Carney","year":"2018","unstructured":"Carney, B. et al. Target engagement imaging of PARP inhibitors in small-cell lung cancer. Nat. Commun. 9, 176 (2018).","journal-title":"Nat. Commun."},{"key":"526_CR55","doi-asserted-by":"publisher","first-page":"e0147752","DOI":"10.1371\/journal.pone.0147752","volume":"11","author":"S Kossatz","year":"2016","unstructured":"Kossatz, S., Weber, W. A. & Reiner, T. Optical imaging of PARP1 in response to radiation in oral squamous cell carcinoma. PLoS ONE 11, e0147752 (2016).","journal-title":"PLoS ONE"},{"key":"526_CR56","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.2967\/jnumed.117.205765","volume":"59","author":"S Kossatz","year":"2018","unstructured":"Kossatz, S. et al. Direct imaging of drug distribution and target engagement of the PARP inhibitor rucaparib. J. Nucl. Med. 59, 1316\u20131320 (2018).","journal-title":"J. Nucl. Med."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0526-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0526-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0526-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T22:34:16Z","timestamp":1670279656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-0526-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1038\/s41551-020-0526-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/663385","asserted-by":"object"}]},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.K., S.G.P., C.B. and T.R. are shareholders of Summit Biomedical Imaging. S.K., S.G.P. and T.R. are co-inventors on filed US patent (WO2016164771), held by Memorial Sloan Kettering Cancer Centre, which covers methods of use for PARPi-FL. T.R. is a co-inventor on US patent (WO2012074840), held by the General Hospital Corporation, which covers the composition of PARPi-FL. B.C. and T.R. are co-inventors on the filed US patent (WO2016033293), held by Memorial Sloan Kettering Cancer Centre, which covers methods for the synthesis of [<sup>18<\/sup>F]PARPi. T.R. is a paid consultant for Theragnostics. M.S. is a co-founder of Aero-Di-Namics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}